» Articles » PMID: 23653285

Determination of Anti-inflammatory Activities of Standardised Preparations of Plant- and Mushroom-based Foods

Overview
Journal Eur J Nutr
Date 2013 May 9
PMID 23653285
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic inflammatory processes contribute to the pathogenesis of many age-related diseases. In search of anti-inflammatory foods, we have systematically screened a variety of common dietary plants and mushrooms for their anti-inflammatory activity.

Methods: A selection of 115 samples was prepared by a generic food-compatible processing method involving heating. These products were tested for their anti-inflammatory activity in murine N11 microglia and RAW 264.7 macrophages, using nitric oxide (NO) and tumour necrosis factor-α (TNF-α) as pro-inflammatory readouts.

Results: Ten food samples including lime zest, English breakfast tea, honey-brown mushroom, button mushroom, oyster mushroom, cinnamon and cloves inhibited NO production in N11 microglia, with IC50 values below 0.5 mg/ml. The most active samples were onion, oregano and red sweet potato, exhibiting IC50 values below 0.1 mg/ml. When these ten food preparations were retested in RAW 264.7 macrophages, they all inhibited NO production similar to the results obtained in N11 microglia. In addition, English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom preparations suppressed TNF-α production, exhibiting IC50 values below 0.5 mg/ml in RAW 264.7 macrophages.

Conclusion: In summary, anti-inflammatory activity in these food samples survived 'cooking'. Provided that individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these foods may be useful in limiting inflammation in a variety of age-related inflammatory diseases. Furthermore, these foods could be a source for the discovery of novel anti-inflammatory drugs.

Citing Articles

Anti-Inflammatory Effect of Medicinal Fungus Cultivated on Hayata.

Hou C, Zhao B, Liu S, Chen Y Food Technol Biotechnol. 2024; 62(3):292-301.

PMID: 39497698 PMC: 11531683. DOI: 10.17113/ftb.62.03.24.8257.


In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.

Chrysanthou M, Estruch I, Rietjens I, Wichers H, Hoppenbrouwers T Nutrients. 2022; 14(2).

PMID: 35057544 PMC: 8777776. DOI: 10.3390/nu14020363.


In Vitro Anti-Inflammatory Activity of Essential Oil and β-Bisabolol Derived from Cotton Gin Trash.

Egbuta M, McIntosh S, Waters D, Vancov T, Liu L Molecules. 2022; 27(2).

PMID: 35056836 PMC: 8779114. DOI: 10.3390/molecules27020526.


Understanding immune-modulatory efficacy in vitro.

Khatua S, Simal-Gandara J, Acharya K Chem Biol Interact. 2021; 352:109776.

PMID: 34906553 PMC: 8665649. DOI: 10.1016/j.cbi.2021.109776.


Investigation of the neuroprotective and neuritogenic effects of halotolerant -derived sorbicillin-like compounds on PC-12 Adh cells.

Kaya Tilki E, Engur Ozturk S, Ozarda M, Canturk Z, Dikmen M Cytotechnology. 2021; 73(6):801-813.

PMID: 34776630 PMC: 8554936. DOI: 10.1007/s10616-021-00498-9.


References
1.
Boulanger E, Daroux M . Peritoneal aging during PD: implication of RAGE, the receptor for AGEs. Nefrologia. 2008; 28 Suppl 6:5-10. View

2.
De Allegri M, Sarker M, Hofmann J, Sanon M, Bohler T . A qualitative investigation into knowledge, beliefs, and practices surrounding mastitis in sub-Saharan Africa: what implications for vertical transmission of HIV?. BMC Public Health. 2007; 7:22. PMC: 1810242. DOI: 10.1186/1471-2458-7-22. View

3.
Ethgen O, Reginster J . Degenerative musculoskeletal disease. Ann Rheum Dis. 2003; 63(1):1-3. PMC: 1754732. DOI: 10.1136/ard.2003.009613. View

4.
van Zoelen M, Yang H, Florquin S, Meijers J, Akira S, Arnold B . Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock. 2009; 31(3):280-4. PMC: 4535325. DOI: 10.1097/SHK.0b013e318186262d. View

5.
Rahmadi A, Steiner N, Munch G . Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease. Clin Chem Lab Med. 2011; 49(3):385-91. DOI: 10.1515/CCLM.2011.079. View